Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)
| dc.contributor.author | Tasci, Elif Senocak | |
| dc.contributor.author | Oyan, Basak | |
| dc.contributor.author | Sonmez, Ozlem | |
| dc.contributor.author | Mutlu, Arda Ulas | |
| dc.contributor.author | Atci, Muhammed Mustafa | |
| dc.contributor.author | Sakin, Abdullah | |
| dc.contributor.author | Oner, Irem | |
| dc.date.accessioned | 2024-02-23T14:27:18Z | |
| dc.date.available | 2024-02-23T14:27:18Z | |
| dc.date.issued | 2024 | |
| dc.department | NEÜ | en_US |
| dc.description.abstract | [Abstract Not Availabe] | en_US |
| dc.identifier.doi | 10.1186/s12885-024-11863-0 | |
| dc.identifier.issn | 1471-2407 | |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.pmid | 38262962 | en_US |
| dc.identifier.scopus | 2-s2.0-85182828807 | en_US |
| dc.identifier.uri | https://doi.org/10.1186/s12885-024-11863-0 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12452/14540 | |
| dc.identifier.volume | 24 | en_US |
| dc.identifier.wos | WOS:001148300200002 | en_US |
| dc.indekslendigikaynak | Web of Science | en_US |
| dc.indekslendigikaynak | Scopus | en_US |
| dc.indekslendigikaynak | PubMed | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Bmc | en_US |
| dc.relation.ispartof | Bmc Cancer | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | [Keyword Not Available] | en_US |
| dc.title | Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024) | en_US |
| dc.type | Correction | en_US |
